CareFusion to buy GE's respiratory, anesthesiology products business
(Reuters) - Medical device maker CareFusion Corp said it will buy GE Healthcare's respiratory care and anesthesiology products business, Vital Signs, for $500 million.
The deal will expand CareFusion's specialty disposables business by adding products for anesthesiology and is expected to be neutral or add modestly to CareFusion's adjusted earnings in fiscal 2014.
For fiscal 2015, the deal is expected to add 5 cents to 8 cents per share to earnings.
(Reporting by Esha Dey in Bangalore; Editing by Don Sebastian)
- IPhone emerges from 'bygone era', reviewers hail bigger handset
- Fed may hint on rate-hike plan as it prepares for policy turn
- Scots' support for independence lags on eve of referendum |
- Boeing, SpaceX win contracts to build 'space taxis' for NASA
- Islamic State campaign tests Obama's commitment to Mideast allies
Major U.S. poultry firms are administering antibiotics to their flocks far more pervasively than regulators realize, posing a potential risk to human health. Full Article